Nakagawa, Mina

Publishing since 1967 (Dinosaur)

Has published 638 publications in 44 years

Number of publications published per year by Nakagawa, Mina. (Source : PubMed)

Distribution of publications types for Nakagawa, Mina. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. Secreted frizzled-related protein-5 (sFRP-5) is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.  Int. J. Cancer  2010  
•  Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H. miR-145, miR-133a and miR-133b: Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.  Int. J. Cancer  2010  
•  Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.  Br. J. Cancer  2010;102;5  
•  Nakagawa M, Kondo M. [NeuroAIDS]  Nippon Rinsho  2010;68;3  
•  Nakanishi R, Nakagawa M, Tokufuchi H, Okumura T, Kuboi S, Kido M. [Effects of smoking on video-assisted thoracic surgery lobectomy for lung cancer]  J. UOEH  2010;32;1  
•  Seto M, Honma K, Nakagawa M. Diversity of genome profiles in malignant lymphoma.  Cancer Sci.  2010;101;3  
•  Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, Iwasa Y, Sugioka K, Naruko T, Arakawa T, Ueda M. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers.  J. Gastroenterol.  2010;45;3  
•  Shimizu Y, Yoshida T, Kato M, Hirota J, Ono S, Nakagawa M, Kobayashi T, Kubota K, Asaka M. Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.  J. Gastroenterol. Hepatol.  2010;25;2  
•  Nakagawa M, Sakamoto N, Ueyama M, Mogushi K, Nagaie S, Itsui Y, Azuma S, Kakinuma S, Tanaka H, Enomoto N, Watanabe M. Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection.  J. Gastroenterol.  2010  
•  Nakagawa M, Yoshimuta T, Higashi M, Takeshita S. High attenuation in abdominal aortic aneurysm.  Intern. Med.  2010;49;6  

[ See timeline ] [ See all publications ]